FindTrial
Sign In

Observation cohort study on hemoperfusion in the treatment of moderate and severe acute organophosphorus poisoning

Observation cohort study on hemoperfusion in the treatment of moderate and severe acute organophosphorus poisoning

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082274
Enrollment
Unknown
Registered
2024-03-26
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organophosphorus poisoning

Interventions

Hemoperfusion group (hemoperfusion and routine treatment):NA
Control group (routine treatment without hemoperfusion):NA

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Acute organophosphorus poisoning was definitely diagnosed, and the time from poisoning to medical treatment was = 24 hours; ? According to serum cholinesterase or clinical symptoms, the degree of poisoning was judged as moderate or severe.

Exclusion criteria

Exclusion criteria: ? At least one day of treatment in another hospital; ? patients without complete prognostic information; ? patients received CPR for more than 10 minutes before admission without ROSC.

Design outcomes

Primary

MeasureTime frame
28-day mortality rate;—

Secondary

MeasureTime frame
Incidence of intermediate syndrome;Mechanical ventilation time;Dosage of vasoactive drugs;Length of ICU stay;Total length of stay;—

Countries

China

Contacts

Public ContactDingyu Tan

Northern Jiangsu People's Hospital

32494845@qq.com+86 180 5106 1672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026